search
Back to results

Physiology as Guidance to Evaluate the Direct Impact of Coronary Lesion Treatment: The PREDICT Study (EASY-PREDICT)

Primary Purpose

Coronary Artery Disease, Stable Angina, Unstable Angina

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
post-PCI FFR
Sponsored by
Laval University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Coronary Artery Disease focused on measuring Coronary Artery Disease, Fractional Flow Reserve, Post-PCI FFR, Angiography, Angioplasty

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Any patient referred for diagnostic coronary angiography and / or possible PCI in native coronary vessels.
  • Successful (< 30% diameter stenosis and normal TIMI 3 flow post-stenting) and uncomplicated PCI
  • All treated lesions stented with drug-eluting stents (except side-branches of bifurcations)

Exclusion Criteria:

  • Lesion in saphenous vein or arterial grafts
  • Allergy to aspirin, thienopyridines or ticagrelor precluding treatment for 30 days
  • Sub-optimal PCI result ( >30% residual diameter stenosis and/or <TIMI3 flow) or peri-procedural complications
  • Acute ST-Elevation MI (culprit lesion)

Sites / Locations

  • IUCPQ - Laval HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Angiographical guidance only

Post-PCI FFR guidance

Arm Description

Standard of care

Post-PCI Fractional Flow Reserve and non-hyperemic pressure ratios measurement

Outcomes

Primary Outcome Measures

Rate of Target Vessel Failure
as the composite of cardiac death, lesion-related MI and target vessel revascularization
Rate of angina-related events
defined as hospitalization for unstable angina and unsolicited medical visits for angina

Secondary Outcome Measures

Final post-PCI pressure ratio values according to lesion location and intervened vessels
In the Physiology group, final pressure ratio (Pd/Pa) values will be collected immediately after randomization, and if further intervention is performed, before completing the intervention.
Final post-PCI FFR values according to lesion location and intervened vessels
In the Physiology group, final FFR values will be collected immediately after randomization, and if further intervention is performed, before completing the intervention.
Final post-PCI dPR values according to lesion location and intervened vessels
In the Physiology group, final dPR values will be collected immediately after randomization, and if further intervention is performed, before completing the intervention.
Final post-PCI physiology pullback curves according to lesion location and intervened vessels
In the Physiology group, final physiology pullback curves will be collected immediately after randomization, and if further intervention is performed, before completing the intervention if possible. Physiology pullback refers to either hyperemic or non-hyperemic pullback.
Rates of unstable angina requiring hospitalization or unsolicited medical visits
Rates of individual components of MACE
including all-cause mortality, MI, TVR and any revascularization

Full Information

First Posted
May 31, 2021
Last Updated
January 28, 2022
Sponsor
Laval University
Collaborators
Opsens, Inc., International Chair on Interventional Cardiology and Transradial Approach
search

1. Study Identification

Unique Protocol Identification Number
NCT04929496
Brief Title
Physiology as Guidance to Evaluate the Direct Impact of Coronary Lesion Treatment: The PREDICT Study
Acronym
EASY-PREDICT
Official Title
Physiology as Guidance to Evaluate the Direct Impact of Coronary Lesion Treatment: the PREDICT Study
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 10, 2021 (Actual)
Primary Completion Date
August 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Laval University
Collaborators
Opsens, Inc., International Chair on Interventional Cardiology and Transradial Approach

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
The purpose of this study is to assess whether the use of physiology parameters as guidance post-percutaneous coronary interventions (PCI) is associated with less risks of target vessel failure (TVF) and angina-related events than standard angiographic guidance.
Detailed Description
Fractional flow reserve (FFR) measurement involves determining the ratio between the maximum achievable blood flow in a diseased coronary artery and the theoretical maximal flow in a normal coronary artery. An FFR of 1.0 is widely accepted as normal. An FFR value less than or equal to 0.80 is generally considered to be associated with myocardial ischemia. FFR is easily measured during routine coronary angiography by using a pressure wire to calculate the ratio between coronary pressure distal to a coronary artery stenosis and aortic pressure under conditions of maximum myocardial hyperemia. this ratio represents the potential decrease in coronary flow distal o the coronary stenosis. Recently, other physiology ratios called non-hyperemic ratios (NHPR) have been developed. Both types of physiology measures (FFR and NHPR) have been increasingly used in cardiac catheterization laboratories as a diagnostic tool. They provide a quantitative assessment of the functional severity of a coronary artery stenosis identified during coronary angiography and cardiac catheterization. However, they are underutilized as tools for the assessment of success of coronary interventions. The PREDICT study is a pilot study which aims to prospectively determine whether post-PCI physiology guidance is associated with better clinical outcomes than standard angiographic guidance.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease, Stable Angina, Unstable Angina, Ischemic Heart Disease, Chest Pain
Keywords
Coronary Artery Disease, Fractional Flow Reserve, Post-PCI FFR, Angiography, Angioplasty

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
220 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Angiographical guidance only
Arm Type
No Intervention
Arm Description
Standard of care
Arm Title
Post-PCI FFR guidance
Arm Type
Experimental
Arm Description
Post-PCI Fractional Flow Reserve and non-hyperemic pressure ratios measurement
Intervention Type
Procedure
Intervention Name(s)
post-PCI FFR
Other Intervention Name(s)
Fractional Flow Reserve, Non-hyperemic pressure ratios
Intervention Description
final invasive physiology measurements after successful stent implantation, followed by functional optimization if physiology indexes remain positive.
Primary Outcome Measure Information:
Title
Rate of Target Vessel Failure
Description
as the composite of cardiac death, lesion-related MI and target vessel revascularization
Time Frame
within 12 months after index PCI;
Title
Rate of angina-related events
Description
defined as hospitalization for unstable angina and unsolicited medical visits for angina
Time Frame
within 12 months after index PCI;
Secondary Outcome Measure Information:
Title
Final post-PCI pressure ratio values according to lesion location and intervened vessels
Description
In the Physiology group, final pressure ratio (Pd/Pa) values will be collected immediately after randomization, and if further intervention is performed, before completing the intervention.
Time Frame
Post-randomization after stent implantation (< 1 hour)
Title
Final post-PCI FFR values according to lesion location and intervened vessels
Description
In the Physiology group, final FFR values will be collected immediately after randomization, and if further intervention is performed, before completing the intervention.
Time Frame
Post-randomization after stent implantation (< 1 hour)
Title
Final post-PCI dPR values according to lesion location and intervened vessels
Description
In the Physiology group, final dPR values will be collected immediately after randomization, and if further intervention is performed, before completing the intervention.
Time Frame
Post-randomization after stent implantation (< 1 hour)
Title
Final post-PCI physiology pullback curves according to lesion location and intervened vessels
Description
In the Physiology group, final physiology pullback curves will be collected immediately after randomization, and if further intervention is performed, before completing the intervention if possible. Physiology pullback refers to either hyperemic or non-hyperemic pullback.
Time Frame
Post-randomization after stent implantation (< 1 hour)
Title
Rates of unstable angina requiring hospitalization or unsolicited medical visits
Time Frame
within 12 months of index procedure
Title
Rates of individual components of MACE
Description
including all-cause mortality, MI, TVR and any revascularization
Time Frame
within 12 months of index procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Any patient referred for diagnostic coronary angiography and / or possible PCI in native coronary vessels. Successful (< 30% diameter stenosis and normal TIMI 3 flow post-stenting) and uncomplicated PCI All treated lesions stented with drug-eluting stents (except side-branches of bifurcations) Exclusion Criteria: Lesion in saphenous vein or arterial grafts Allergy to aspirin, thienopyridines or ticagrelor precluding treatment for 30 days Sub-optimal PCI result ( >30% residual diameter stenosis and/or <TIMI3 flow) or peri-procedural complications Acute ST-Elevation MI (culprit lesion)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Olivier F. Bertrand, MD, PhD
Phone
4186568711
Ext
5947
Email
olivier.bertrand@fmed.ulaval.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Michele Jadin
Phone
4186568711
Email
michele.jadin@criucpq.ulaval.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Olivier F. Bertrand, MD, PhD
Organizational Affiliation
International Chair on Interventional Cardiology and Transradial Approach
Official's Role
Principal Investigator
Facility Information:
Facility Name
IUCPQ - Laval Hospital
City
Quebec
ZIP/Postal Code
G1V 4G5
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Olivier F Bertrand, MD PhD
Phone
418 656 8711
Email
olivier.bertrand@crhl.ulaval.ca
First Name & Middle Initial & Last Name & Degree
Olivier F Bertrand, MD PhD
First Name & Middle Initial & Last Name & Degree
Tomas Cieza, MD
First Name & Middle Initial & Last Name & Degree
Paul Poirier, MD, PhD

12. IPD Sharing Statement

Learn more about this trial

Physiology as Guidance to Evaluate the Direct Impact of Coronary Lesion Treatment: The PREDICT Study

We'll reach out to this number within 24 hrs